Real Talk on Real Dollars

How to Get Your MedTech Ideas Funded

May 28, 2025 | Hosted by Grand Avenue Software

Whether you’re pre-commercial or mid-prototyping, you’ve probably asked yourself:  “How do we raise money without overbuilding or falling short?”

In this 45-minute panel + live Q&A, we’ll skip the vague advice and get straight into what actually moves the needle for early-stage Med Tech companies today. 

Featured Panelists

  • Morgan Evans of Avio MedTech –  MedTech investor and former founder focused on early-stage strategy and capital formation 
  • Steve Anderson of Perceptis Medical – Early-stage investor with a focus on go-to-market execution and commercial traction in regulated markets 
  • Steve Cohen of Grand Avenue Software – VP of Business Operations, specializing in quality systems and compliance automation 

  • “If you’re fundraising, make that your full-time job.” 

  • “Your job is to make it de-risked enough for someone else to take the next step.” 

  • “Prove there’s a market. I don’t care how cool the prototype is.” 

  • “Get clear on who you’re building for—and who you’re not.” 

Key Takeaways from the Panel

Know Your Investor Audience 

  • Tailor your pitch: Device investors ≠ biotech investors. Understand their risk/reward mindset. 
  • Milestones matter: Funding is often tranche-based and tied to regulatory/technical progress. 
  • Segment the market: Angels, family offices, SBIR/STTR grants precede venture capital. 

Early-Stage Strategy is Scrappy, Not Sexy 

  • Non-dilutive funding first: Grants, pitch contests, and partnerships validate your idea early. 
  • Think beyond VC: Many founders thrive through slow, deliberate growth—not blitzscaling. 
  • Regulatory strategy = investor confidence: Pre-Subs are a signal you understand the game. 

How to Win Over Investors

  • Traction > tech: Show early demand, real-world interest, and some form of customer validation. 
  • CEO story > slide deck: Clarity, credibility, and conviction beat polish. 
  • Honest storytelling: “Tell me what sucks.” Funders want transparency over bravado. 

Cap Table and Culture 

  • Cap table hygiene is essential. Over-equitizing early kills flexibility later. 
  • Beware of deadweight equity. One investor walked away when a founder held just 12%. 

Common Mistakes to Avoid 

  • Don’t assume MedTech follows SaaS timelines. It’s slower and more expensive. 
  • Don’t overbuild. Validate first, scale second. 
  • Don’t delay FDA conversations. Regulatory missteps can cost years and millions. 

Take the First $ Seriously 

  • First money sets the tone—terms, culture, boardroom dynamics. 
  • Avoid giving up board control too early. Communicate clearly and early with funders. 

Ready to Operationalize Your Vision? 

If you’re building toward FDA clearance, ISO certification, or commercialization, Grand Avenue Software’s modular eQMS is built for you. Our system scales with your growth and helps you stay compliant without breaking your budget. 

Talk to our team to learn how Grand Avenue can help you stay audit-ready, investor-ready, and market-ready. 

See the system our customers trust